Organization Profile

Related Organization(s)

You just read:

Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis

News provided by

Virobay, Inc.

Mar 18, 2013, 08:00 ET